Strength in Synergy.
Powerful Impact.
Advancing the Future of Cancer Therapies
We’re dedicated to expanding the possibilities for patients by developing novel approaches to optimize current and future standards of care.
Learn about our clinically validated and differentiated scientific approach.
Our ScienceUnleashing the Full Power of the Immune System
We’re exploring the potential of evorpacept to become a cornerstone therapy upon which the future of immuno-oncology can be built.
Development Plan for EvorpaceptLeading the Evolution
Science driven with a tenacious focus, our team is uniquely capable and committed to taking cancer therapies to the next level.
Meet Our Leaders
ALX Oncology is a clinical-stage biopharmaceutical company advancing therapies that boost the immune system to treat cancer.
Our lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built.